Favorable outcome of chronic myeloid leukemia co-expressing e13a2 and e14a2 transcripts, treated with nilotinib

MeSH terms

• Adult
• Aged
• Aged, 80 and over
• Chromosomes, Human, Pair 22* / genetics
• Chromosomes, Human, Pair 22* / metabolism
• Chromosomes, Human, Pair 9* / genetics
• Chromosomes, Human, Pair 9* / metabolism
• Disease-Free Survival
• Female
• Follow-Up Studies
• Fusion Proteins, bcr-abl* / blood
• Fusion Proteins, bcr-abl* / genetics
• Humans
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / blood
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / drug therapy
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / genetics
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / mortality
• Male
• Middle Aged
• Pyrimidines / administration & dosage*
• RNA, Messenger* / blood
• RNA, Messenger* / genetics
• RNA, Neoplasm* / blood
• RNA, Neoplasm* / genetics
• Survival Rate
• Translocation, Genetic*